Skip to main content

Markman Ruling in Third Wave/Digene HPV Suit Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, July 27.
1. Judge's Markman Ruling Sides With Third Wave in Digene HPV IP Row (from July 25)
2. California Court Tosses Gen-Probe Complaint Against Digene; Arbitration on HPVs Open (from July 23)
3. Illumina to Co-develop SNP Chip for Vascular Disease with NHLBI, Penn, and Broad (from July 23)
4. PerkinElmer's LAS Head to Replace Summe as CEO in February; Q2 Revenue, Profits Rise (from July 27)
5. ABI Accelerates Next-Gen Sequencer Launch; Fiscal Q4 Sales Rise 7 Percent (from July 25)
The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.